Retatrutide Dosage, Explained Simply (With the Research)
TL;DR
Retatrutide is a triple-receptor agonist studied for metabolic outcomes. Trials used a slow weekly titration from a low starting dose. The cited dosage chart shows the exact studied steps; the calculator handles reconstitution math.
Why everyone is talking about retatrutide
Retatrutide (LY3437943) is a "triple agonist" — it acts on three receptors involved in metabolism at once. In clinical research it produced some of the largest weight changes reported for this class of compounds.
How it was dosed in trials
Studies used a slow titration — starting low and increasing over weeks to reduce side effects. You can see the exact studied steps, frequency and duration on our cited retatrutide dosage chart, where every row links to its source.
Reconstitution
Like other research peptides, retatrutide is reconstituted with bacteriostatic water. Our calculator turns your vial size and target dose into syringe units.
See the dosage chart — Retatrutide
An investigational triple-agonist studied for weight and metabolic outcomes.
FAQ
What is retatrutide?
Retatrutide (LY3437943) is an investigational triple agonist studied in clinical trials for weight and metabolic outcomes. It is a research compound.
How is retatrutide dosed?
Research used a gradual weekly titration starting at a low dose and increasing over several weeks. See the cited dosage chart for the exact studied steps.
For research and educational use only. Not medical advice.
EN
BR
ES
FR